Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy.
Giada Dal ColloPaul Takam KamgaPublished in: Cancers (2023)
Immune checkpoint inhibitors (ICIs) are pharmaceutical agents capable of disrupting immune checkpoint signaling, leading to T-cell activation and a robust anti-tumor response [...].
Keyphrases